Treatment Options

The most successful treatment plan today for AD/HD is considered to be the Multimodal Treatment Plan because there are several studies to support its effectiveness. The most well-known study is the NIMH Multimodal Treatment Study of Children with ADHD (MTA), which is an ongoing, multi-site, cooperative agreement treatment study of children conducted by the National Institute of Mental Health. The MTA study has demonstrated that on average, carefully monitored medication management with monthly follow-up is more effective than intensive behavioural treatment for AD/HD symptoms, for periods lasting as long as 14 months. For some outcomes that are important in the daily functioning of these children (e.g., academic performance, familial relations), the combination of behavioural therapy and AD/HD medication was necessary to produce improvements better than community care. All children tended to improve over the course of the study, but they differed in the relative amount of improvement, with the carefully-done medication management approaches generally showing the greatest improvement. Therefore, medication alone is not necessarily the best treatment for every child, and families often need to pursue other treatments in combination with medication.
Promo 1
Promo 1
Promo 1

ADHD Europe asks for better provisions for Teenagers with ADHD who continue to need access to mental health services after they turn 18.
This must be a priority across Europe so please sign the Declaration:
DECLARATION HERE

Click here to get this resource in other languages:


Support Us

We are a non-profit organization staffed entirely by volunteers whose aim it is to provide excellent support, resources, workshops and conferences for those affected by AD/HD, Asperger’s Syndrome, Dyslexia and other related comorbid conditions. We are thankful for all donations to help us achieve this.

Support Us arrow

Join Our Mailing List